{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T20:08:53Z","timestamp":1792958933567,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T00:00:00Z","timestamp":1588636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006012","name":"Christian Doppler Forschungsgesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006012","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Aspects of Medicine"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.mam.2020.100862","type":"journal-article","created":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T09:40:33Z","timestamp":1589881233000},"page":"100862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"special_numbering":"C","title":["Intravenous iron supplementation therapy"],"prefix":"10.1016","volume":"75","author":[{"given":"Benedikt","family":"Schaefer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Meindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Tilg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Zoller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 4","key":"10.1016\/j.mam.2020.100862_bib1","doi-asserted-by":"crossref","first-page":"iv271","DOI":"10.1093\/annonc\/mdy323","article-title":"Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines","volume":"29","author":"Aapro","year":"2018","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.mam.2020.100862_bib2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/ajh.25060","article-title":"Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: a randomized trial","volume":"93","author":"Adkinson","year":"2018","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.mam.2020.100862_bib3","series-title":"FDA Drug Safety Communication: FDA Strengthens Warnings and Changes Prescribing Instructions to Decrease the Risk of Serious Allergic Reactions with Anemia Drug Feraheme (Ferumoxytol)","author":"Administration","year":"2015"},{"key":"10.1016\/j.mam.2020.100862_bib4","series-title":"New Recommendations to Manage Risk of Allergic Reactions with Intravenous Iron-Containing Medicines","author":"Agency","year":"2013"},{"key":"10.1016\/j.mam.2020.100862_bib5","series-title":"Ireland. INFeD (IRON DEXTRAN INJECTION USP)) [package Insert]","author":"Allergan","year":"2009"},{"key":"10.1016\/j.mam.2020.100862_bib6","series-title":"Waltham, MA. FERAHEME (Ferumoxytol Injection) [package Insert]","year":"2019"},{"issue":"2","key":"10.1016\/j.mam.2020.100862_bib7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/ALN.0000000000000463","article-title":"Practice guidelines for perioperative blood management: an updated report by the American society of anesthesiologists task force on perioperative blood management*","volume":"122","author":"American Society of Anesthesiologists Task Force on Perioperative Blood","year":"2015","journal-title":"Anesthesiology"},{"issue":"Suppl. 6","key":"10.1016\/j.mam.2020.100862_bib8","doi-asserted-by":"crossref","first-page":"1559S","DOI":"10.3945\/ajcn.117.155804","article-title":"Current understanding of iron homeostasis","volume":"106","author":"Anderson","year":"2017","journal-title":"Am. J. Clin. Nutr."},{"issue":"25","key":"10.1016\/j.mam.2020.100862_bib9","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.mam.2020.100862_bib10","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/ajh.25564","article-title":"A prospective, multi-center, randomized comparison of iron isomaltoside 1000 versus iron sucrose in patients with iron deficiency anemia; the FERWON-IDA trial","volume":"94","author":"Auerbach","year":"2019","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.mam.2020.100862_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mayocp.2014.10.007","article-title":"The safety of intravenous iron preparations: systematic review and meta-analysis","volume":"90","author":"Avni","year":"2015","journal-title":"Mayo Clin. Proc."},{"issue":"3","key":"10.1016\/j.mam.2020.100862_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ph11030082","article-title":"Intravenous irons: from basic science to clinical practice","volume":"11","author":"Bhandari","year":"2018","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.mam.2020.100862_bib13","article-title":"Safety and efficacy of iron isomaltoside 1000\/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial","author":"Bhandari","year":"2020","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.mam.2020.100862_bib14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1172\/JCI101690","article-title":"The anemia of infection; hypoferremia, hypercupremia, and alterations in porphyrin metabolism in patients","volume":"25","author":"Cartwright","year":"1946","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.mam.2020.100862_bib15","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1053\/ajkd.2001.28587","article-title":"Intravenous iron sucrose: establishing a safe dose","volume":"38","author":"Chandler","year":"2001","journal-title":"Am. J. Kidney Dis."},{"issue":"10","key":"10.1016\/j.mam.2020.100862_bib16","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/EJA.0b013e3283499e3b","article-title":"Preoperative evaluation of the adult patient undergoing non-cardiac surgery: guidelines from the European Society of Anaesthesiology","volume":"28","author":"De Hert","year":"2011","journal-title":"Eur. J. Anaesthesiol."},{"issue":"20","key":"10.1016\/j.mam.2020.100862_bib17","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1001\/jama.2016.0962","article-title":"Risk of anaphylaxis with intravenous iron products","volume":"315","author":"DeLoughery","year":"2016","journal-title":"J. Am. Med. Assoc."},{"issue":"3","key":"10.1016\/j.mam.2020.100862_bib18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/ecco-jcc\/jju009","article-title":"European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases","volume":"9","author":"Dignass","year":"2015","journal-title":"J Crohns Colitis"},{"issue":"4","key":"10.1016\/j.mam.2020.100862_bib19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0272-6386(96)90463-1","article-title":"The safety of intravenous iron dextran in hemodialysis patients","volume":"28","author":"Fishbane","year":"1996","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"10.1016\/j.mam.2020.100862_bib20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/pharmaceutics3010012","article-title":"The pharmacokinetics and pharmacodynamics of iron preparations","volume":"3","author":"Geisser","year":"2011","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.mam.2020.100862_bib21","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1136\/gut.2010.228874","article-title":"Guidelines for the management of iron deficiency anaemia","volume":"60","author":"Goddard","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.mam.2020.100862_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1182\/blood.V1.2.129.129","article-title":"Observations on the effect of massive doses of iron given intravenously to patients with hypochromic anemia","volume":"1","author":"Goetsch","year":"1946","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.mam.2020.100862_bib23","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ejpb.2011.03.016","article-title":"A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications","volume":"78","author":"Jahn","year":"2011","journal-title":"Eur. J. Pharm. Biopharm. : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V"},{"key":"10.1016\/j.mam.2020.100862_bib24","series-title":"Effectiveness of Intravenous Iron Treatment vs Standard Care in Patients with Heart Failure and Iron Deficiency: a Randomised, Open-Label Multicentre Trial (IRONMAN)","author":"Kalra","year":"2015"},{"issue":"2","key":"10.1016\/j.mam.2020.100862_bib25","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000334939","article-title":"Iron sucrose promotes endothelial injury and dysfunction and monocyte adhesion\/infiltration","volume":"35","author":"Kamanna","year":"2012","journal-title":"Am. J. Nephrol."},{"issue":"3","key":"10.1016\/j.mam.2020.100862_bib26","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/j.ajkd.2007.06.008","article-title":"KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target","volume":"50","author":"Kdoqi","year":"2007","journal-title":"Am. J. Kidney Dis."},{"issue":"7 Suppl. l","key":"10.1016\/j.mam.2020.100862_bib27","first-page":"S18","article-title":"Epinephrine: the drug of choice for anaphylaxis-a statement of the world allergy organization","volume":"1","author":"Kemp","year":"2008","journal-title":"World Allergy Organ. J."},{"key":"10.1016\/j.mam.2020.100862_bib28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.freeradbiomed.2018.10.413","article-title":"Non-transferrin-bound iron transporters","volume":"133","author":"Knutson","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mam.2020.100862_bib29","doi-asserted-by":"crossref","first-page":"763576","DOI":"10.1155\/2015\/763576","article-title":"Intravenous iron therapy in patients with iron deficiency anemia: dosing considerations","volume":"2015","author":"Koch","year":"2015","journal-title":"Anemia"},{"issue":"11","key":"10.1016\/j.mam.2020.100862_bib30","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1681\/ASN.2013080838","article-title":"Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD","volume":"25","author":"Kuo","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.mam.2020.100862_bib31","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/7727","article-title":"Transferrin receptor is necessary for development of erythrocytes and the nervous system","volume":"21","author":"Levy","year":"1999","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.mam.2020.100862_bib32","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/vox.12773","article-title":"Canadian expert consensus: management of hypersensitivity reactions to intravenous iron in adults","volume":"114","author":"Lim","year":"2019","journal-title":"Vox Sang."},{"key":"10.1016\/j.mam.2020.100862_bib33","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/blood.V23.3.354.354","article-title":"The treatment of iron-deficiency anemia with intravenous iron dextran","volume":"23","author":"Marchasin","year":"1964","journal-title":"Blood"},{"key":"10.1016\/j.mam.2020.100862_bib34","series-title":"KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease","first-page":"1","author":"McMurray","year":"2012"},{"issue":"5","key":"10.1016\/j.mam.2020.100862_bib35","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1046\/j.1523-1755.2002.00314.x","article-title":"Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran","volume":"61","author":"Michael","year":"2002","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.mam.2020.100862_bib36","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2016.12.034","article-title":"A red carpet for iron metabolism","volume":"168","author":"Muckenthaler","year":"2017","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.mam.2020.100862_bib37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/anae.13773","article-title":"International consensus statement on the peri-operative management of anaemia and iron deficiency","volume":"72","author":"Munoz","year":"2017","journal-title":"Anaesthesia"},{"issue":"1","key":"10.1016\/j.mam.2020.100862_bib38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s40264-019-00868-5","article-title":"Reported severe hypersensitivity reactions after intravenous iron administration in the European economic area (EEA) before and after implementation of risk minimization measures","volume":"43","author":"Nathell","year":"2020","journal-title":"Drug Saf."},{"issue":"4","key":"10.1016\/j.mam.2020.100862_bib39","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10534-015-9845-9","article-title":"Physico-chemical properties of the new generation IV iron preparations ferumoxytol, iron isomaltoside 1000 and ferric carboxymaltose","volume":"28","author":"Neiser","year":"2015","journal-title":"Biometals"},{"issue":"6556","key":"10.1016\/j.mam.2020.100862_bib40","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0140-6736(49)91958-3","article-title":"Preparation and standardization of saccharated iron oxide for intra venous administration","volume":"1","author":"Nissim","year":"1949","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.mam.2020.100862_bib42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/nyas.13461","article-title":"Complexity of intravenous iron nanoparticle formulations: implications for bioequivalence evaluation","volume":"1407","author":"Pai","year":"2017","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"5","key":"10.1016\/j.mam.2020.100862_bib43","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1365-2141.2011.09012.x","article-title":"UK guidelines on the management of iron deficiency in pregnancy","volume":"156","author":"Pavord","year":"2012","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.mam.2020.100862_bib44","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.3945\/ajcn.114.103366","article-title":"Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review","volume":"102","author":"Peyrin-Biroulet","year":"2015","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.mam.2020.100862_bib45","series-title":"MONOFERRIC (Ferric Derisomaltose) [package Insert]","year":"2018"},{"issue":"3","key":"10.1016\/j.mam.2020.100862_bib46","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/path.1700310302","article-title":"The fate of colloidal iron administered intravenously","volume":"31","author":"Polson","year":"1928","journal-title":"J. Pathol."},{"issue":"11","key":"10.1016\/j.mam.2020.100862_bib47","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiencydagger","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur. Heart J."},{"issue":"8","key":"10.1016\/j.mam.2020.100862_bib48","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur. J. Heart Fail."},{"issue":"3","key":"10.1016\/j.mam.2020.100862_bib49","first-page":"355","article-title":"Acute and sub-acute effect of ferric carboxymaltose on inflammation and adhesion molecules in patients with predialysis chronic renal failure","volume":"33","author":"Prats","year":"2013","journal-title":"Nefrologia"},{"issue":"11","key":"10.1016\/j.mam.2020.100862_bib50","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.3324\/haematol.2014.111492","article-title":"Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management","volume":"99","author":"Rampton","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.mam.2020.100862_bib51","series-title":"LLC. Ferrlecit (Sodium Ferric Gluconate Complex in Sucrose Injection) [package Insert]","year":"2013"},{"issue":"2","key":"10.1016\/j.mam.2020.100862_bib52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/WOX.0b013e318211496c","article-title":"World allergy organization guidelines for the assessment and management of anaphylaxis","volume":"4","author":"Simons","year":"2011","journal-title":"World Allergy Organ. J."},{"issue":"1","key":"10.1016\/j.mam.2020.100862_bib53","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40413-015-0080-1","article-title":"2015 update of the evidence base: world Allergy Organization anaphylaxis guidelines","volume":"8","author":"Simons","year":"2015","journal-title":"World Allergy Organ. J."},{"issue":"3","key":"10.1016\/j.mam.2020.100862_bib54","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/path.1711710313","article-title":"Tissue iron loading and histopathological changes in hypotransferrinaemic mice","volume":"171","author":"Simpson","year":"1993","journal-title":"J. Pathol."},{"issue":"21","key":"10.1016\/j.mam.2020.100862_bib55","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.1111\/bph.13268","article-title":"Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management","volume":"172","author":"Szebeni","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.mam.2020.100862_bib56","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1182\/blood-2007-05-090019","article-title":"Autocrine formation of hepcidin induces iron retention in human monocytes","volume":"111","author":"Theurl","year":"2008","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.mam.2020.100862_bib57","first-page":"251","article-title":"Physiology of haemoglobin","volume":"12","author":"Thomas","year":"2012","journal-title":"Cont. Educ. Anaesth. Crit. Care Pain"},{"key":"10.1016\/j.mam.2020.100862_bib58","series-title":"Switzerland. Venofer (Iron Sucrose Injection, USP) [package Insert]","author":"Vifor (International) Inc","year":"2018"},{"key":"10.1016\/j.mam.2020.100862_bib59","series-title":"Switzerland. INJECTAFER\u00ae (Ferric Carboxymaltose Injection), [package Insert]","author":"Vifor (International) Inc","year":"2020"},{"key":"10.1016\/j.mam.2020.100862_bib60","article-title":"Atherosclerosis is aggravated by iron overload and ameliorated by dietary and pharmacological iron restriction","author":"Vinchi","year":"2019","journal-title":"Eur. Heart J."},{"issue":"19","key":"10.1016\/j.mam.2020.100862_bib61","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1001\/jama.2015.15572","article-title":"Comparative risk of anaphylactic reactions associated with intravenous iron products","volume":"314","author":"Wang","year":"2015","journal-title":"J. Am. Med. Assoc."},{"issue":"20","key":"10.1016\/j.mam.2020.100862_bib62","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1001\/jama.2016.0965","article-title":"Risk of anaphylaxis with intravenous iron products","volume":"315","author":"Wang","year":"2016","journal-title":"J. Am. Med. Assoc."},{"issue":"1","key":"10.1016\/j.mam.2020.100862_bib63","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1182\/blood-2018-06-856500","article-title":"Anemia of inflammation","volume":"133","author":"Weiss","year":"2019","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.mam.2020.100862_bib64","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1172\/JCI103883","article-title":"Red cell, plasma and blood volume in healthy men measured by radiochromium (Cr51) cell tagging and hematocrit: influence of age, somatotype and habits of physical activity on the variance after regression of volumes to height and weight combined","volume":"38","author":"Wennesland","year":"1959","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.mam.2020.100862_bib65","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/jbmr.1923","article-title":"Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women","volume":"28","author":"Wolf","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"23","key":"10.1016\/j.mam.2020.100862_bib66","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124486","article-title":"Randomized trial of intravenous iron-induced hypophosphatemia","volume":"3","author":"Wolf","year":"2018","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.mam.2020.100862_bib67","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jama.2019.22450","article-title":"Effects of iron isomaltoside vs ferric carboxymaltose on hypophosphatemia in iron-deficiency anemia: two randomized clinical trials","volume":"323","author":"Wolf","year":"2020","journal-title":"J. Am. Med. Assoc."},{"issue":"6","key":"10.1016\/j.mam.2020.100862_bib68","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.mam.2020.100862_bib69","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MNH.0000000000000329","article-title":"Iron-induced hypophosphatemia: an emerging complication","volume":"26","author":"Zoller","year":"2017","journal-title":"Curr. Opin. Nephrol. Hypertens."}],"container-title":["Molecular Aspects of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299720300388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299720300388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T18:13:44Z","timestamp":1758824024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098299720300388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":68,"alternative-id":["S0098299720300388"],"URL":"https:\/\/doi.org\/10.1016\/j.mam.2020.100862","relation":{},"ISSN":["0098-2997"],"issn-type":[{"value":"0098-2997","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous iron supplementation therapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Aspects of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mam.2020.100862","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100862"}}